Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2010 1
2013 1
2016 1
2017 2
2018 5
2020 1
2021 4
2022 11
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Targeting glutamine dependence through GLS1 inhibition suppresses ARID1A-inactivated clear cell ovarian carcinoma.
Wu S, Fukumoto T, Lin J, Nacarelli T, Wang Y, Ong D, Liu H, Fatkhutdinov N, Zundell JA, Karakashev S, Zhou W, Schwartz LE, Tang HY, Drapkin R, Liu Q, Huntsman DG, Kossenkov AV, Speicher DW, Schug ZT, Van Dang C, Zhang R. Wu S, et al. Among authors: van dang c. Nat Cancer. 2021 Feb;2(2):189-200. doi: 10.1038/s43018-020-00160-x. Epub 2021 Jan 11. Nat Cancer. 2021. PMID: 34085048 Free PMC article.
Peer Review: Value Added and Civility.
Dang CV. Dang CV. Cancer Res. 2022 Apr 1;82(7):1157-1158. doi: 10.1158/0008-5472.CAN-22-0765. Cancer Res. 2022. PMID: 35373287 No abstract available.
Cancer Metabolism: the Known, Unknowns.
Dang CV. Dang CV. Biochim Biophys Acta Rev Cancer. 2018 Aug;1870(1):1. doi: 10.1016/j.bbcan.2018.07.006. Epub 2018 Aug 13. Biochim Biophys Acta Rev Cancer. 2018. PMID: 30336841 No abstract available.
Cancer Moonshot 2.0.
Agus DB, Jaffee EM, Van Dang C. Agus DB, et al. Among authors: van dang c. Lancet Oncol. 2021 Feb;22(2):164-165. doi: 10.1016/S1470-2045(21)00003-6. Epub 2021 Jan 19. Lancet Oncol. 2021. PMID: 33482124 No abstract available.
The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission.
Anderson KC, Cantley LC, Dalla-Favera R, Dang CV, Diaz LA, DuBois RN, Flaherty KT, Greenberg PD, Loda M, Mardis ER, Platz EA, Pollak MN, Schreiber RD, Siu LL, Teicher BA. Anderson KC, et al. Among authors: dang cv. Cancer Immunol Res. 2022 Nov 2;10(11):1282-1288. doi: 10.1158/2326-6066.CIR-22-0782. Cancer Immunol Res. 2022. PMID: 36321298 No abstract available.
The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission.
Anderson KC, Cantley LC, Dalla-Favera R, Dang CV, Diaz LA, DuBois RN, Flaherty KT, Greenberg PD, Loda M, Mardis ER, Platz EA, Pollak MN, Schreiber RD, Siu LL, Teicher BA. Anderson KC, et al. Among authors: dang cv. Mol Cancer Ther. 2022 Nov 3;21(11):1625-1631. doi: 10.1158/1535-7163.MCT-22-0655. Mol Cancer Ther. 2022. PMID: 36325690 No abstract available.
The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission.
Anderson KC, Cantley LC, Dalla-Favera R, Dang CV, Diaz LA, DuBois RN, Flaherty KT, Greenberg PD, Loda M, Mardis ER, Platz EA, Pollak MN, Schreiber RD, Siu LL, Teicher BA. Anderson KC, et al. Among authors: dang cv. Mol Cancer Res. 2022 Nov 3;20(11):1591-1597. doi: 10.1158/1541-7786.MCR-22-0804. Mol Cancer Res. 2022. PMID: 36325685 No abstract available.
The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission.
Anderson KC, Cantley LC, Dalla-Favera R, Dang CV, Diaz LA, DuBois RN, Flaherty KT, Greenberg PD, Loda M, Mardis ER, Platz EA, Pollak MN, Schreiber RD, Siu LL, Teicher BA. Anderson KC, et al. Among authors: dang cv. Cancer Res. 2022 Nov 2;82(21):3861-3867. doi: 10.1158/0008-5472.CAN-22-2453. Cancer Res. 2022. PMID: 36321264 No abstract available.
29 results